Trade Mark Journal No.2026/034 21 August 2026

UK00004399220 8 June 2026 (5)

FLGR242

International priority date claimed: 20 January 2026 (United States of America) (99604473)

Class 5: Biopharmaceutical preparations for the treatment of recombinant protein pharmaceuticals for medical use.

Epiq Bio Consulting, LLC

Representative: HGF Limited